EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Drugs and Cell-Based Therapies for the Prevention and Treatment of Neonatal Brain Injury

Melanie A McNally, Janet S Soul

Clinics in Perinatology · 2026-09 · 53 (3) · 727-740

DOI: 10.1016/j.clp.2026.05.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Perinatology, 2026-09. Verfasst von Melanie A McNally und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Harvard Medical School and Massachusetts General Hospital, Boston, MA 02114, USA. Hauptthemen laut MEDLINE: Hypoxia-Ischemia, Brain, Neuroprotective Agents, Leukomalacia, Periventricular, Stem Cell Transplantation. Die Arbeit nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The international burden of neonatal brain injury (NBI) remains significant with enormous potential for therapeutic intervention. Recent large trials have demonstrated no neuroprotection with either erythropoietin or darbepoetin for term or pre-term brain injury. Neuroprotective strategies with strong evidence are currently limited to antenatal steroids, antenatal magnesium, and supportive care for pre-term NBI and therapeutic hypothermia for term hypoxic-ischemic encephalopathy. Of the pharmacologic strategies currently being investigated clinically, the agents with the highest likelihood of success and closest to clinical implementation include melatonin, topiramate, and stem cell-based therapies. More therapies to prevent or treat NBI are urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Ischemia, BrainNeuroprotective AgentsLeukomalacia, PeriventricularStem Cell TransplantationBrain InjuriesHumansInfant, NewbornErythropoietinMelatoninFructoseTopiramateDarbepoetin alfaHypothermia, Induced

Stichwörter der Autor:innen

ErythropoietinHypoxic-ischemic encephalopathyMagnesiumNeonatal brain injuryNeuroprotectionPerinatal strokePeriventricular leukomalaciaStem cells

Substanzen

Neuroprotective AgentsErythropoietinMelatoninFructoseTopiramateDarbepoetin alfa

Autor:innen und Institutionen

  • Department of Neurology, Harvard Medical School and Massachusetts General Hospital, Boston, MA 02114, USA.
  • Fetal-Neonatal Neurology Program, Department of Neurology, Harvard Medical School and Boston Children's Hospital, Boston, MA 02115, USA. Electronic address: janet.soul@childrens.harvard.edu.

Zitieren

APA

McNally, M. A., & Soul, J. S. (2026). Drugs and Cell-Based Therapies for the Prevention and Treatment of Neonatal Brain Injury. Clinics in Perinatology, 53(3), 727-740. https://doi.org/10.1016/j.clp.2026.05.003

Vancouver

McNally MA, Soul JS. Drugs and Cell-Based Therapies for the Prevention and Treatment of Neonatal Brain Injury. Clinics in Perinatology. 2026;53(3):727-740. doi:10.1016/j.clp.2026.05.003

BibTeX
@article{McNally2026,
  author = {McNally, Melanie A and Soul, Janet S},
  title = {Drugs and Cell-Based Therapies for the Prevention and Treatment of Neonatal Brain Injury},
  journal = {Clinics in Perinatology},
  year = {2026},
  volume = {53},
  number = {3},
  pages = {727--740},
  doi = {10.1016/j.clp.2026.05.003}
}
Kostenlos starten →